{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:35:54Z","timestamp":1770910554307,"version":"3.50.1"},"reference-count":42,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2010]]},"DOI":"10.1536\/ihj.51.188","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T06:04:59Z","timestamp":1276581899000},"page":"188-192","source":"Crossref","is-referenced-by-count":9,"title":["Effects of Efonidipine, an L- and T-type Calcium Channel Blocker, on the Renin-Angiotensin-Aldosterone System in Chronic Hemodialysis Patients"],"prefix":"10.1536","volume":"51","author":[{"given":"Nobuyuki","family":"Nakano","sequence":"first","affiliation":[{"name":"Department of Hypertension and Cardiorenal Medicine, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Ishimitsu","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Cardiorenal Medicine, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Cardiorenal Medicine, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Inada","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Cardiorenal Medicine, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Okamura","sequence":"additional","affiliation":[{"name":"Utsunomiya Chuoh Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Ohba","sequence":"additional","affiliation":[{"name":"Ohba Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Utsunomiya Chuoh Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","unstructured":"1. Collins AJ, Foley R, Herzog C, <i>et al<\/i>. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008; 51: S1-320."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.4009\/jsdt.42.1"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200307000-00003"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2003.11.037"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res 2005; 28: 191-202. (Review)","DOI":"10.1291\/hypres.28.191"},{"key":"7","unstructured":"7. Ishimitsu T, Matsumoto N, Seta H, Yanaka H, Matsuoka H. Implication of angiotensin II as a cardiovascular risk factor in hemodialysis patients. J Jpn Coll Angiol 2007; 47: 383-89."},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90492-1"},{"key":"9","unstructured":"9. Mittal SK, Kowalski E, Trenkle J, <i>et al<\/i>. Prevalence of hypertension in a hemodialysis population. Clin Nephrol 1999; 51: 77-82."},{"key":"10","unstructured":"10. Grekas D, Bamichas G, Bacharaki D, Goutzaridis N, Kasimatis E, Tourkantonis A. Hypertension in chronic hemodialysis patients: current view on pathophysiology and treatment. Clin Nephrol 2000; 53: 164-8."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tanaka H, Shigenobu K. Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development. J Pharmacol Sci 2005; 99: 214-20. (Review)","DOI":"10.1254\/jphs.FMJ05002X5"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000197539.12685.f5"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.493"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Conion PJ, Walshe JJ, Heinle SK, Minda S, Krucoff M, Schwab SJ. Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol 1996; 7: 2658-63.","DOI":"10.1681\/ASN.V7122658"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917120-00013"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.1703"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yanaka H, Ishimitsu T, Takahashi M, Minami J, Ono H. Analysis of factors influencing the left ventricular mass in chronic hemodialysis patients. J Jpn Soc Dial Ther 2002; 35: 1211-7.","DOI":"10.4009\/jsdt.35.1211"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00066-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Steigerwalt S, Zafar A, Mesiha N, Gardin J, Provenzano R. Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis. Am J Nephrol 2007; 27: 159-63.","DOI":"10.1159\/000100106"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994; 90: 2786-96.","DOI":"10.1161\/01.CIR.90.6.2786"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.253"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1159\/000049060"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.02.022"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9631844"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.192"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(04)00816-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-9.","DOI":"10.1161\/01.CIR.99.18.2434"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001657"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36340"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Suzuki H, Kanno Y, Sugahara S, <i>et al<\/i>. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial. Am J Kidney Dis 2008; 52: 501-6.","DOI":"10.1053\/j.ajkd.2008.04.031"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.326"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lopez-Gomez JM, Verde E, Perez-Garcia R. Blood pressure, left ventricular hypertrophy and long-term prognosis in hemodialysis patients. Kidney Int Suppl 1998; 68: S92-8. (Review)","DOI":"10.1046\/j.1523-1755.1998.06820.x"},{"key":"33","unstructured":"33. Ozkahya M, Toz H, Qzerkan F, <i>et al<\/i>. Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-60."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Gunal AI, Karaca I, Aygen B, Yavuzkir M, Dogukan A, Celiker H. Strict fluid volume control and left ventricular hypertrophy in hypertensive patients on chronic haemodialysis: a cross-sectional study. J Int Med Res 2004; 32: 70-7.","DOI":"10.1177\/147323000403200112"},{"key":"35","unstructured":"35. Lins RL, Elseviers M, Rogiers P, <i>et al<\/i>. Importance of volume factors in dialysis related hypertension. Clin Nephrol 1997; 48: 29-33."},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.3.485"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.621"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.78"},{"key":"39","unstructured":"39. Navar LG, Harrison-Bernard LM, Imig JD, Wang CT, Cervenka L, Mitchell KD. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade. J Am Soc Nephrol 1999; 10: S266-72. (Review)"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00088-7"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2003.03867.x"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.213"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/ihj\/51\/3\/51_3_188\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T13:13:30Z","timestamp":1635513210000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/ihj\/51\/3\/51_3_188\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.51.188","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}